Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry.

Ding WY, Fawzy AM, Romiti GF, Proietti M, Pastori D, Huisman MV, Lip GY, Abban DW, Abdul N, Abud AM, Adams F, Addala S, Adragão P, Ageno W, Aggarwal R, Agosti S, Agostoni P, Aguilar F, Linares JA, Aguinaga L, Ahmed J, Aiello A, Ainsworth P, Aiub JR, Al-Dallow R, Alderson L, Velasco JAA, Alexopoulos D, Manterola FA, Aliyar P, Alonso D, da Costa FAA, Amado J, Amara W, Amelot M, Amjadi N, Ammirati F, Andrade M, Andrawis N, Annoni G, Ansalone G, Ariani MK, Arias JC, Armero S, Arora C, Aslam MS, Asselman M, Audouin P, Augenbraun C, Aydin S, Ayryanova I, Aziz E, Backes LM, Badings E, Bagni E, Baker SH, Bala R, Baldi A, Bando S, Banerjee S, Bank A, Esquivias GB, Barr C, Bartlett M, Kes VB, Baula G, Behrens S, Bell A, Benedetti R, Mazuecos JB, Benhalima B, Bergler-Klein J, Berneau JB, Berrospi P, Berti S, Berz A, Best E, Bettencourt P, Betzu R, Bhagwat R, Bhatta L, Biscione F, Bisignani G, Black T, Bloch MJ, Bloom S, Blumberg E, Bo M, Bøhmer E, Bollmann A, Bongiorni MG, Boriani G, Boswijk DJ, Bott J, Bottacchi E, Kalan MB, Bradman D, Brautigam D, Breton N, Brouwers PJ, Browne K, Cortada JB, Bruni A, Brunschwig C, Buathier H, Buhl A, Bullinga J, Cabrera JW, Caccavo A, Cai S, Caine S, Calò L, Calvi V, Sánchez MC, Candeias R, Capuano V, Capucci A, Caputo R, Rizo TC, Cardona F, da Costa Darrieux FC, Vera YCD, Carolei A, Carreño S, Carvalho P, Cary S, Casu G, Cavallini C, Cayla G, Celentano A, Cha TJ, Cha KS, Chae JK, Chalamidas K, Challappa K, Chand SP, Chandrashekar H, Chartier L, Chatterjee K, Ayala CAC, Cheema A, Cheema A, Chen L, Chen SA, Chen JH, Chiang FT, Chiarella F, Chih-Chan L, Cho YK, Choi JI, Choi DJ, Chouinard G, Chow DHF, Chrysos D, Chumakova G, Valenzuela EJJRC, Nica NC, Cislowski DJ, Clay A, Clifford P, Cohen A, Cohen M, Cohen S, Colivicchi F, Collins R, Colonna P, Compton S, Connolly D, Conti A, Buenostro GC, Coodley G, Cooper M, Coronel J, Corso G, Sales JC, Cottin Y, Covalesky J, Cracan A, Crea F, Crean P, Crenshaw J, Cullen T, Darius H, Dary P, Dascotte O, Dauber I, Davalos V, Davies R, Davis G, Davy JM, Dayer M, De Biasio M, De Bonis S, De Caterina R, De Franceschi T, de Groot JR, De Horta J, De La Briolle A, de la Pena Topete G, de Paola AAV, de Souza W, de Veer A, De Wolf L, Decoulx E, Deepak S, Defaye P, Munoz FDC, Brkljacic DD, Deumite NJ, Di Legge S, Diemberger I, Dietz D, Dionísio P, Dong Q, dos Santos FR, Dotcheva E, Doukky R, D’Souza A, Dubrey S, Ducrocq X, Dupljakov D, Duque M, Dutta D, Duvilla N, Eaton ADRDCB, Eaves W, Ebels-Tuinbeek LA, Ehrlich C, Eichinger-Hasenauer S, Eisenberg SJ, Jabali AE, Shahawy ME, Hernandes ME, Izal AE, Evonich R, Evseeva O, Ezhov A, Fahmy R, Fang Q, Farsad R, Fauchier L, Favale S, Fayard M, Fedele JL, Fedele F, Fedorishina O, Fera SR, Ferreira LGG, Ferreira J, Ferri C, Ferrier A, Ferro H, Finsen A, First B, Fischer S, Fonseca C, Almeida LF, Forman S, Frandsen B, French W, Friedman K, Friese A, Fruntelata AG, Fujii S, Fumagalli S, Fundamenski M, Furukawa Y, Gabelmann M, Gabra N, Gadsbøll N, Galinier M, Gammelgaard A, Ganeshkumar P, Gans C, Quintana AG, Gartenlaub O, Gaspardone A, Genz C, Georger F, Georges JL, Georgeson S, Giedrimas E, Gierba M, Ortega IG, Gillespie E, Giniger A, Giudici MC, Gkotsis A, Glotzer TV, Gmehling J, Gniot J, Goethals P, Goldbarg S, Goldberg R, Goldmann B, Golitsyn S, Gómez S, Mesa JG, Gonzalez VB, Hermosillo JAG, López VMG, Gorka H, Gornick C, Gorog D, Gottipaty V, Goube P, Goudevenos I, Graham B, Greer GS, Gremmler U, Grena PG, Grond M, Gronda E, Grönefeld G, Gu X, Torres Torres IG, Guardigli G, Guevara C, Guignier A, Gulizia M, Gumbley M, Günther A, Ha A, Hahalis G, Hakas J, Hall C, Han B, Han S, Hargrove J, Hargroves D, Harris KB, Haruna T, Hayek E, Healey J, Hearne S, Heffernan M, Heggelund G, Heijmeriks JA, Hemels M, Hendriks I, Henein S, Her SH, Hermany P, Del Río JEH, Higashino Y, Hill M, Hisadome T, Hishida E, Hoffer E, Hoghton M, Hong K, Hong Sk, Horbach S, Horiuchi M, Hou Y, Hsing J, Huang CH, Huckins D, Hughes k, Hung AHEKC, Hwang GS, Ikpoh M, Imberti D, Ince H, Indolfi C, Inoue S, Irles D, Iseki H, Israel CN, Iteld B, Iyer V, Jackson-Voyzey E, Jaffrani N, Jäger F, James M, Jang SW, Jaramillo N, Jarmukli N, Jeanfreau RJ, Jenkins RD, Sánchez CJ, Jimenez J, Jobe R, Joen-Jakobsen T, Jones N, Jorge JCM, Jouve B, Jung BC, Jung KT, Jung W, Kachkovskiy M, Kafkala K, Kalinina L, Kallmünzer B, Kamali F, Kamo T, Kampus P, Kashou H, Kastrup A, Katsivas A, Kaufman E, Kawai K, Kawajiri K, Kazmierski JF, Keeling P, Saraiva JFK, Ketova G, Khaira AS, Khripun A, Kim DI, Kim YH, Kim NH, Kim DK, Kim JS, Kim JS, Kim KS, Kim Jb, Kinova E, Klein A, Kmetzo JJ, Kneller GL, Knezevic A, Koh SMA, Koide S, Kollias A, Kooistra JA, Koons J, Koschutnik M, Kostis WJ, Kovacic D, Kowalczyk J, Koziolova N, Kraft P, Kragten JA, Krantz M, Krause L, Krenning BJ, Krikke F, Kromhout Z, Krysiak W, Kumar P, Kümler T, Kuniss M, Kuo JY, Küppers A, Kurrelmeyer K, Kwak CH, Laboulle B, Labovitz A, Ter Lai W, Lam A, Lam YY, Zanetti FL, Landau C, Landini G, Figueiredo EL, Larsen T, Lavandier K, LeBlanc J, Lee MH, Lee CH, Lehman J, Leitão A, Lellouche N, Lelonek M, Lenarczyk R, Lenderink T, González SL, Leong-Sit P, Leschke M, Ley N, Li Z, Li X, Li W, Li X, Lichy C, Lieber I, Rodriguez RHL, Lin H, Lip GY, Liu F, Liu H, Esperon GL, Navarro NL, Lo E, Lokshyn S, López A, López-Sendón JL, Filho AML, Lorraine RS, Luengas CA, Luke R, Luo M, Lupovitch S, Lyrer P, Ma C, Ma G, Madariaga I, Maeno K, Magnin D, Maid G, Mainigi SK, Makaritsis K, Malhotra R, Manning R, Manolis A, Hurtado HAM, Mantas I, Jattin FM, Maqueda V, Marchionni N, Ortuno FM, Santana AM, Martinez J, Maskova P, Hernandez NM, Matsuda K, Maurer T, Mauro C, May E, Mayer N, McClure J, McCormack T, McGarity W, McIntyre H, McLaurin B, Palomino FAM, Melandri F, Meno H, Menzies D, Mercader M, Meyer C, Meyer BJ, Miarka J, Mibach F, Michalski D, Michel P, Chreih RM, Mikdadi G, Mikus M, Milicic D, Militaru C, Minaie S, Minescu B, Mintale I, Mirault T, Mirro MJ, Mistry D, Miu NV, Miyamoto N, Moccetti T, Mohammed A, Nor AM, Mollerus M, Molon G, Mondillo S, Moniz P, Mont L, Montagud V, Montaña O, Monti C, Moretti L, Mori K, Moriarty A, Morka J, Moschini L, Moschos N, Mügge A, Mulhearn TJ, Muresan C, Muriago M, Musial W, Musser CW, Musumeci F, Nageh T, Nakagawa H, Nakamura Y, Nakayama T, Nam GB, Nanna M, Natarajan I, Nayak HM, Naydenov S, Nazlić J, Nechita AC, Nechvatal L, Negron SA, Neiman J, Neuenschwander FC, Neves D, Neykova A, Miguel RN, Nijmeh G, Nizov A, Campos RN, Nossan J, Novikova T, Nowalany-Kozielska E, Nsah E, Fragoso JCN, Nurgalieva S, Nuyens D, Nyvad O, de Los Rios Ibarra MO, O’Donnell P, O’Donnell M, Oh S, Oh YS, Oh D, O’Hara G, Oikonomou K, Olivares C, Oliver R, Ruiz RO, Olympios C, omaszuk-Kazberuk A, Asensi JO, jose eP, Padilla Padilla FG, Rios VP, Pajes G, Pandey AS, Paparella G, Paris F, Park HW, Park JS, Parthenakis F, Passamonti E, Patel RJ, Patel J, Patel M, Patrick J, Jimenez RP, Paz A, Pengo V, Pentz W, Pérez B, Ríos AMP, Pérez-Cabezas A, Perlman R, Persic V, Perticone F, Peters TK, Petkar S, Pezo LF, Pflücke C, Pham DN, Phillips RT, Phlaum S, Pieters D, Pineau J, Pinter A, Pinto F, Pisters R, Pivac N, Pocanic D, Podoleanu C, Politano A, Poljakovic Z, Pollock S, Garcéa JP, Poppert H, Porcu M, Reino AP, Prasad N, Précoma DB, Prelle A, Prodafikas J, Protasov K, Pye M, Qiu Z, Quedillac JM, Raev D, Grado CAR, Rahimi S, Raisaro A, Rama B, Ramos R, Ranieri M, Raposo N, Rashba E, Rauch-Kroehnert U, Reddy R, Renda G, Reza S, Ria L, Richter D, Rickli H, Rieker W, Vera TR, Ritt LE, Roberts D, Briones IR, Escudero AER, Pascual CR, Roman M, Romeo F, Ronner E, Roux JF, Rozkova N, Rubacek M, Rubalcava F, Russo AM, Rutgers MP, Rybak K, Said S, Sakamoto T, Salacata A, Salem A, Bodes RS, Saltzman MA, Salvioni A, Vallejo GS, Fernández MS, Saporito WF, Sarikonda K, Sasaoka T, Sati H, Savelieva I, Scala PJ, Schellinger P, Scherr C, Schmitz L, Schmitz KH, Schmitz B, Schnabel T, Schnupp S, Schoeniger P, Schön N, Schwimmbeck P, Seamark C, Searles G, Seidl KH, Seidman B, Sek J, Sekaran L, Serrati C, Shah N, Shah V, Shah A, Shah S, Sharma VK, Shaw L, Sheikh KH, Shimizu N, Shimomura H, Shin DG, Shin ES, Shite J, Sibilio G, Silver F, Sime I, Simmers TA, Singh N, Siostrzonek P, Smadja D, Smith DW, Snitman M, Filho DS, Soda H, Sofley C, Sokal A, Yan YSO, Sotolongo R, de Souza OF, Sparby JA, Spinar J, Sprigings D, Spyropoulos AC, Stakos D, Steinwender C, Stergiou G, Stiell I, Stoddard M, Stoikov A, Streb W, Styliadis I, Su G, Su X, Sudnik W, Sukles K, Sun X, Swart H, Szavits-Nossan J, Taggeselle J, Takagi Y, Takhar APS, Tamm A, Tanaka K, Tanawuttiwat T, Tang S, Tang A, Tarsi G, Tassinari T, Tayal A, Tayebjee M, Berg JM, Tesloianu D, The SH, Thomas D, Timsit S, Tobaru T, Tomasik AR, Torosoff M, Touze E, Trendafilova E, Tsai WK, Tse HF, Tsutsui H, Tu TM, Tuininga Y, Turakhia M, Turk S, Turner W, Tveit A, Tytus R, Valadão C, van Bergen PF, van de Borne P, van den Berg BJ, van der Zwaan C, Van Eck M, Vanacker P, Vasilev D, Vasilikos V, Vasilyev M, Veerareddy S, Miño MV, Venkataraman A, Verdecchia P, Versaci F, Vester EG, Vial H, Victory J, Villamil A, Vincent M, Vlastaris A, Dahl Jv, Vora K, Vranian RB, Wakefield P, Wang N, Wang M, Wang X, Wang F, Wang T, Warner AL, Watanabe K, Wei J, Weimar C, Weiner S, Weinrich R, Wen MS, Wiemer M, Wiggers P, Wilke A, Williams D, Williams ML, Witzenbichler B, Wong B, Wong KSL, Wozakowska-Kaplon B, Wu S, Wu RC, Wunderlich S, Wyatt N, Wylie J, Xu Y, Xu X, Yamanoue H, Yamashita T, Yan PYB, Yang T, Yao J, Yeh KH, Yin WH, Yotov Y, Zahn R, Zarich S, Zenin S, Zeuthen EL, Zhang H, Zhang D, Zhang X, Zhang P, Zhang J, Zhao SP, Zhao Y, Zhao Z, Zheng Y, Zhou J, Zimmermann S, Zini A, Zizzo S, Zong W, Steven Zukerman L (2024)


Publication Type: Journal article

Publication year: 2024

Journal

Book Volume: 57

Pages Range: 39-49

Journal Issue: 1

DOI: 10.1007/s11239-023-02866-y

Abstract

The 2MACE score was specifically developed as a risk-stratification tool in atrial fibrillation (AF) to predict cardiovascular outcomes. We evaluated the predictive ability of the 2MACE score in the GLORIA-AF registry. All eligible patients from phase II/III of the prospective global GLORIA-AF registry were included. Major adverse cardiac events (MACEs) were defined as the composite outcome of stroke, myocardial infarction and cardiovascular death. Cox proportional hazards were used to examine the relationship between the 2MACE score and study outcomes. Predictive capability of the 2MACE score was investigated using receiver-operating characteristic curves. A total of 25,696 patients were included (mean age 71 years, female 44.9%). Over 3 years, 1583 MACEs were recorded. Patients who had MACE were older, with more cardiovascular risk factors and were less likely to be managed using a rhythm-control strategy. The median 2MACE score in the MACE and non-MACE groups were 2 (IQR 1-3) and 1 (IQR 0-2), respectively (p < 0.001). The 2MACE score was positively associated with an increase in the risk of MACE, with a score of ≥ 2 providing the best combination of sensitivity (69.6%) and specificity (51.6%), HR 2.47 (95% CI, 2.21-2.77). The 2MACE score had modest predictive performance for MACE in patients with AF (AUC 0.655 (95% CI, 0.641-0.669)). Our analysis in this prospective global registry demonstrates that the 2MACE score can adequately predict the risk of MACE (defined as myocardial infarction, CV death and stroke) in patients with AF. Clinical trial registration: http://www.clinicaltrials.gov . Unique identifiers: NCT01468701, NCT01671007 and NCT01937377.

How to cite

APA:

Ding, W.Y., Fawzy, A.M., Romiti, G.F., Proietti, M., Pastori, D., Huisman, M.V.,... Steven Zukerman, L. (2024). Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry. Journal of Thrombosis and Thrombolysis, 57(1), 39-49. https://dx.doi.org/10.1007/s11239-023-02866-y

MLA:

Ding, Wern Yew, et al. "Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry." Journal of Thrombosis and Thrombolysis 57.1 (2024): 39-49.

BibTeX: Download